peoplePerson
S. Vincent Rajkumar
Myeloma expert who wrote the diagnostic criteria the field uses and a persistent critic of drug prices.
Hematologist who led the International Myeloma Working Group's updated diagnostic criteria and the randomised trials establishing lenalidomide-dexamethasone dosing. Editor-in-chief of Blood Cancer Journal.
Role
Professor of Medicine, Division of Hematology, Mayo Clinic
Institution
Specialisms
Multiple myelomaPlasma cell disordersDrug pricing
Pages like this
not linked directly; found by shared links- CollectionMultiple Myeloma Research Foundation (MMRF)
Shares R-ISS / R2-ISS staging, MRD negativity (myeloma, 10⁻⁵ / 10⁻⁶), BCMA, Multiple myeloma.
- PersonShaji K. Kumar
Shares MRD negativity (myeloma, 10⁻⁵ / 10⁻⁶), Mayo Clinic, Multiple myeloma.
- IdeaMRD-guided treatment-free intervals in myeloma
Shares MRD negativity (myeloma, 10⁻⁵ / 10⁻⁶), Multiple myeloma.
- ProductAnitocabtagene autoleucel
Shares BCMA, Multiple myeloma.
- InstitutionMayo Clinic Comprehensive Cancer Center – Arizona
Shares Mayo Clinic, Multiple myeloma.
- IdeaHospital-made CAR-T under one shared regulatory master file
Shares BCMA, Multiple myeloma.
- InstitutionUnion Hospital, Tongji Medical College
Shares BCMA, Multiple myeloma.
- ProductLinvoseltamab
Shares BCMA, Multiple myeloma.